OverviewChartNewsTraderScreen

L&S Knock-Out BIO/  DE000LX3MDB8  /

Lang & Schwarz
2024-08-01  10:59:19 PM Chg.-0.14 Bid10:59:19 PM Ask10:59:19 PM Underlying Strike price Expiration date Option type
0.46EUR -23.33% 0.46
Bid Size: -		 0.50
Ask Size: -		 BB BIOTECH AG 38.4585 EUR 2078-12-31 Call
GlobeNewswire 04-02 Abivax reports 2023 financial results and operational update
GlobeNewswire 03-28 Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire 2023-11-27 Arvinas Announces Oversubscribed $350 Million Private Placement
GlobeNewswire 2022-03-08 NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
GlobeNewswire 2021-06-17 Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
TeleTrader 2021-04-15 Incidence of blood clots in Pfizer, Moderna, AZ vaccines similar- report
TeleTrader 2021-04-14 EU to get 50M Pfizer COVID vaccines in Q2 rather than Q4
TeleTrader 2020-11-11 Pfizer, BioNTech grant EU 200 million vaccine doses
GlobeNewswire 2019-12-16 Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire 2018-10-19 Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire 2018-01-02 Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire 2017-12-06 Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030
GlobeNewswire 2017-10-19 Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire 2016-12-02 Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire 2016-10-21 Biotech stocks continue to advance
GlobeNewswire 2016-10-11 BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 2016-10-11 Ad hoc: BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 2016-07-29 Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire 2016-07-22 BB Biotech: Stabilization of biotech sector in the second quarter of 2016
GlobeNewswire 2016-07-15 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 2016-07-14 BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
GlobeNewswire 2016-07-11 BB Biotech AG with after-tax loss in the first half year of 2016
GlobeNewswire 2016-06-23 BB Biotech AG :Release of the Home Member State according to Article 2c of the WpHG (the German Secu...
GlobeNewswire 2016-04-22 BB BIOTECH AG: Challenging first quarter for biotech investments
GlobeNewswire 2016-04-13 BB Biotech AG with after-tax loss in the first quarter of 2016